Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;9(6):419-28.
doi: 10.4088/pcc.v09n0603.

Economic outcomes associated with atypical antipsychotics in bipolar disorder: a systematic review

Rachael L Fleurence  1 , Mary Lou Chatterton, Julia M Dixon, Kitty Rajagopalan
Affiliations

Economic outcomes associated with atypical antipsychotics in bipolar disorder: a systematic review

Rachael L Fleurence et al. Prim Care Companion J Clin Psychiatry. 2007.

Abstract

Objective: Bipolar disorder is a serious condition that is costly to the health care system. Atypical antipsychotics are more expensive than conventional treatments. From a policy-making perspective, the additional cost must be justified by improved outcomes. The objective of this study was to conduct a systematic review to determine the relative costs and cost-effectiveness associated with atypical antipsychotics in bipolar disorder.

Data sources: We conducted a systematic review of the literature in PubMed and EMBASE from January 1985 through October 2005, including published studies and conference proceedings. Databases were searched using predefined terms.

Study selection: Studies were included if they were claims data analyses, trial-based economic evaluations, or cost-effectiveness analyses using models. Data were extracted using predefined tables.

Data synthesis: Fourteen studies were identified. Seven were medical claims database analyses, 4 were trial-based economic evaluations, and 3 were cost-effectiveness models. Eight of these studies were conference proceedings. The studies did not provide sufficient information to determine any ranking of interventions in terms of least to most costly in overall resource consumption or in terms of their relative cost-effectiveness. Where comparable, results tended to be inconsistent.

Conclusion: There is a scarcity of economic studies in this field. A reference case outlining how to address the complex interplay between effectiveness, safety, adherence, and quality of life and their impact on resource use and costs is needed to contribute to improving the treatment of patients with bipolar disorder while making the best use of scarce health resources.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Studies Identified for the Economic Search
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kessler RC, Chiu WT, and Demler O. et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 62:617–627. - PMC - PubMed
    1. Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin. 2004;20:139–154. - PubMed
    1. Leidy NK, Palmer C, and Murray M. et al. Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder: psychometric performance of four self-report measures. J Affect Disord. 1998 48:207–214. - PubMed
    1. Dinan TG. Lithium in bipolar mood disorder. BMJ. 2002;324:989–990. - PMC - PubMed
    1. Hirschfeld RM, Vornik LA. Bipolar disorder—costs and comorbidity. Am J Manag Care. 2005;11:S85–S90. - PubMed